How important is this statement. L1 Capital has completed, (SIGNIFICANT DUE DILIGENCE VIA THEIR SPECIALIST MEDICAL CONSULTANT)
PRIOR TO EXECUTING THE PLACEMENT AGREEMENT.
They have confidence in what CHM have, simple as that.
Chimeric’s Executive Chairman Paul Hopper said: “We are delighted to have the support of a
leading fund manager like L1 Capital, with a strong interest in life science investing. L1’s
commitment is testament to the quality of the Company’s clinical assets, having completed
significant due diligence via their specialist medical consultant based in Israel prior to executing
the placement agreement.
- Forums
- ASX - By Stock
- CHM
- Ann: A$30 million Equity Placement Agreement with L1 Capital
Ann: A$30 million Equity Placement Agreement with L1 Capital, page-12
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.002(10.5%) |
Mkt cap ! $18.39M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 2.0¢ | $30.13K | 1.439M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 623541 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 423206 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 623541 | 0.020 |
5 | 739999 | 0.019 |
8 | 648975 | 0.018 |
4 | 1007660 | 0.017 |
12 | 2743217 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 423206 | 1 |
0.022 | 1004129 | 7 |
0.023 | 250000 | 2 |
0.024 | 400000 | 3 |
0.025 | 545000 | 2 |
Last trade - 15.53pm 25/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |